Scrip's Five Must-Know Things - 4 March 2024

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: optimistic outlook for biopharma IPOs; Boehringer’s promising MASH results; Viking emerges as obesity contender; Incyte looks to portfolio diversification; and a look at China’s HPV vaccine market. https://scrip.citeline.com/SC149879/Quick-Listen-Scrips-Five-MustKnow-Things